Given a paragraph, generate a claim that is supported by the given paragraph. 1) The claim must contain information from within the paragraph. 2) A sentence within the paragraph can be used as a claim. 3) The claim should not have contradictions within the paragraph. 4) The claim should be at most one sentence long.

[Q]: At the last minute, he changed his mind when his young daughter grabbed his arm and begged him: “Daddy, don’t die.”  Unlike Jang, many people do not pull back from the brink in South Korea, which has had the highest suicide rate in the developed world for nine straight years, often drinking pesticide as their way out. But a decade after Jang’s brush with death, a ban on fatal pesticides is credited with cutting the number of suicides by 11 percent last year, the first drop in six years. The government restricted production of Gramoxone, a herbicide linked to suicides, in 2011 and outlawed its sale and storage last year. “The number of suicides by poisoning including Gramoxone fell by 477, which accounts for about 27 percent of the total decrease in the number of people committing suicide,” Lee Jae-won, an official at Statistics Korea, said last week after the government released the latest figures. Pesticide was the method of choice for almost a quarter of the South Koreans who killed themselves between 2006 and 2010, according to a government report to parliament. In the highly competitive society of Asia’s fourth-largest economy, experts say people who end up alone battling pressure for good school grades or from financial burdens have little in the way of a safety net. Despite the improvement in the suicide rate, more than 14,000 South Koreans killed themselves last year. Elderly people living in rural areas are a particularly high-risk group. Since the 1950s, older generations have been fixated on South Korea becoming more competitive and productive, a side effect of rapid industrialisation that turned a war-damaged country into one of the richest in the world. Kim Hyun-chung, a psychiatrist at the Korean Association for Suicide Prevention, sees social stigmas as a major reason for the high suicide rate. Many South Koreans who are depressed or under heavy stress are reluctant to bring up issues like mental illness or an inability to cope, he said. “The ban on toxic pesticides obviously led to the decline in the suicide rate because that is the easiest means of suicide for elderly people in rural towns,” Kim said. “But we still have bridges and charcoal briquettes.”  To help limit access to lethal chemicals, the Life Insurance Philanthropy Foundation launched a campaign to provide pesticide lockers to farming towns with high rates of depression. The foundation, set up by private insurance firms, says no one from the villages with the lockers has committed suicide over the past three years, compared with one or two people from each village who had killed themselves in past years. “The lockers help reduce the impulse to get hold of pesticides because they have to find keys to open them,” Chung Bong-eun, an official at the foundation, told Reuters. The 2012 figures may offer a glimmer of hope, but the latest comparisons by the Organisation for Economic Co-operation and Development showed South Korea was by far the most suicidal society, followed by Hungary, Russia and Japan. For Jang, working two jobs is still tough, but he regrets trying to kill himself and is happy to have his life to share with his two daughters. While he sees the ban on pesticides as a positive step, he feels for others who are under duress. “Old and young people have their own pain from either quick economic development or unemployment,” he said. “I hope the government will care more about people’s health.”
[A]: Pesticide ban cuts South Korea's high suicide rate - a bit.


[Q]: Thirteen search warrants involving marijuana cultivation were served Monday by Riverside County sheriff’s deputies and state Department of Fish and Wildlife personnel in the unincorporated Aguanga area. In addition to the eradicated plants, 2,356 pounds of processed marijuana and 14 firearms were seized, the Sheriff″s Department said. One of the grows was using an extremely toxic pesticide that is banned in the United States, the department noted. “Marijuana cultivation negatively impacts the environment in many ways including diminishing and poisoning the water table and pesticides adversely affecting the health of neighboring residents,” the department said. Aguanga is about 55 miles (88.5 kilometers) north of San Diego.
[A]: Search warrants target illegal Southern California pot grows.


[Q]: A pharmacist counts pills in a pharmacy in Toronto in this January 31, 2008 file photo. Sales of prescription drugs in the United States grew by just 3.8 percent in 2007, marking the lowest growth rate since 1961, according to data compiled by IMS Health. REUTERS/Mark Blinch Total U.S. prescription drug sales reached $286.5 billion last year with slowing growth blamed on factors including patent expirations of lucrative medicines that opened the door to cheaper generic versions. Other reasons cited by IMS in its annual U.S. Pharmaceutical Market Performance Review were fewer new product approvals, safety concerns, and the leveling of year-over-year growth from the Medicare Part D program. The 3.8 percent growth rate compares to 8 percent growth seen in 2006. “The moderating growth trend that began in 2001 resumed last year following the one-time impact on market growth in 2006 from the implementation of Medicare Part D,” Murray Aitken, IMS’s senior vice president for healthcare insight, said in a statement. Cholesterol drugs, such as Pfizer Inc’s Lipitor, once again led all therapy groups with prescription sales of $18.4 billion in 2007 despite a 15.4 percent decline in sales, primarily due to the availability of cheaper generics. Acid reflux medicines known as proton pump inhibitors, including AstraZeneca’s Nexium, ranked second with prescription sales of $14.1 billion and 2.8 percent growth. Antipsychotics, such as Eli Lilly and Co’s Zyprexa, overtook antidepressants as the third largest therapeutic class with $13.1 billion in sales and a 12.1 percent growth rate, according to IMS, which provides industry data on drug prescriptions and sales. Brand name drugs with some $17 billion in sales lost patent protection in 2007, helping drive prescription volume growth of 10 percent for generic medicines. Generic drugs claimed 67.3 percent of U.S. prescriptions dispensed in 2007, IMS found. IMS is forecasting compound annual U.S. pharmaceutical sales growth of 3 percent to 6 percent through 2012, noting that new biotech medicines and vaccines as well as the expected launch of a handful of drugs with at least $1 billion a year potential will partially offset major patent expirations. Some $13 billion in branded products are likely to start facing generic competition this year, IMS said. “The U.S. pharmaceutical market has entered a new era — one characterized by more modest growth due to the continuing impact of new generics products, fewer and more narrowly indicated novel medications and closer scrutiny of safety issues,” Aitken said.
[A]:
U.S. drug sales grew at slowest rate since 1961: IMS.